Key result
Systemic inflammation remains a major untreated risk in ASCVD and CKD, highlighting key nephrology educational gaps.
Answers are grounded in this paper and cite their sources.
There is a significant need for further medical education to raise awareness among nephrologists regarding the role of systemic inflammation and hsCRP testing in patients with ASCVD and CKD.
Lack of effective treatment options for SI remains the most common unmet need for patients with ASCVD and CKD. Further medical education is needed to raise awareness among nephrologists about the role of SI and hsCRP testing.
No takes yet. Share an insight, caveat, or question.
Perkovic et al. (2025) studied this question. Systemic inflammation in patients with ASCVD and CKD lacks effective treatment options, representing a major unmet need that requires further medical education among nephrologists.
Synapse has enriched 10 related papers. Consider them for comparative context: